Stage IV Colorectal Cancer: Lee's Patient Story

Patient Info: Lee, Male, 50s | Stage IV

Metastatic Site: Liver

Lee initially reached no evidence of disease after chemotherapy and right hemicolectomy, but the cancer recurred in the liver about 1 year later, requiring FOLFIRI and liver resection with major postoperative complications.

The Patient StoryRead more →

Stage I Colorectal Cancer: Rachel's Survivor Story

Patient Info: Rachel, Female, Under 40 | Stage I

As of June 2026, Rachel’s story described Stage I colon cancer treated with colectomy, no chemotherapy needed, and an oncologist-confirmed NED status, with lingering digestive and scar-tissue effects from surgery.

The Patient StoryRead more →

Stage II HR-Positive Breast Cancer: Bethany's Patient Story

Patient Info: Bethany W., Female, Under 40 | Stage II

Biomarkers: ER-positive; hormone-positive

As of June 2026, Bethany described care for late Stage II/early Stage III ER-positive breast cancer, beginning with AC chemotherapy and Taxol after scans showed no distant spread, with surgery, radiation, and hormone therapy planned as next phases.

The Patient StoryRead more →

Stage 0 HR-Positive Invasive Ductal Carcinoma: Natalie's Survivor Story

Patient Info: Natalie, Female | Stage 0

Biomarkers: ER-positive

As of June 2026, Natalie was living after Stage 0 DCIS, later nipple/Paget's disease recurrence, and 20 surgeries through May 2019, with a full life and ongoing attention to physical changes after reconstruction.

The Patient StoryRead more →

Stage I Invasive Ductal Carcinoma: Rachel's Patient Story

Patient Info: Rachel, Female | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

As of June 2026, Rachel had completed double mastectomy and chemotherapy for Stage IB breast cancer and remained on planned 10-year tamoxifen therapy, with ongoing joint/muscle pain, weight gain, and survivorship effects.

The Patient StoryRead more →

Stage III Triple-Negative Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage III

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of June 2026, Stephanie described being a 10-year survivor after Stage III BRCA1-positive triple-negative breast cancer, with remission shown after chemotherapy and no recurrence described.

The Patient StoryRead more →

Stage III HR-Positive Invasive Lobular Carcinoma: Tina's Patient Story

Patient Info: Tina, Female, Under 40 | Stage III

Biomarkers: ER-positive

As of June 2026, Tina was in survivorship after double mastectomy, AC-T chemotherapy, radiation, and ongoing hormone therapy with daily tamoxifen and Zoladex every 3 months.

The Patient StoryRead more →

Stage III Breast Cancer: Andrea's Survivor Story

Patient Info: Andrea, Female, Under 40 | Stage III

Completed chemotherapy, mastectomy/reconstruction, and radiation for Stage IIB-to-Stage III breast cancer diagnosed during pregnancy, and later described survivorship, parenting, fatigue, relationship strain, and recovery after treatment.

The Patient StoryRead more →

Stage II Invasive Ductal Carcinoma: Margaret's Survivor Story

Patient Info: Margaret, Female | Stage II

Biomarkers: Onco-typing score 18; hormone-responsive tumor described; exact receptor status not reported

As of June 2026, Margaret’s story described completed surgery, chemotherapy, radiation, and later reconstruction for Stage II IDC/DCIS breast cancer, with survivorship focused on recovery, neuropathy, and integrative support rather than an explicit NED claim.

The Patient StoryRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Doreen's Patient Story

Patient Info: Doreen, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Doreen had completed TCHP chemotherapy with a complete response before surgery and had undergone lumpectomy and radiation for Stage IIA triple-positive breast cancer.

The Patient StoryRead more →

Stage III Lung Cancer: Bonnie's Patient Story

Patient Info: Bonnie Ulrich, Female, 40s | Stage III

Biomarkers: CA-125 elevated during 2019 workup; no lung cancer driver biomarker reported

After surgery-only Stage I lung cancer and 13 years in remission, Bonnie was later diagnosed with Stage III lung cancer in 2019; the later treatment regimen is not reported.

The Patient StoryRead more →

Stage III Colorectal Cancer: Catherine's Patient Story

Patient Info: Catherine, Female | Stage III

Catherine had a complete pathological response after chemoradiation and surgery for Stage III rectal cancer, then continued adjuvant Xeloda/oxaliplatin while waiting for post-treatment scans before accepting an NED label.

The Patient StoryRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Callie's Survivor Story

Patient Info: Callie, Female, Under 40 | Stage II

Biomarkers: ER-positive

As of June 2026, Callie described survivorship after mastectomy, ACT chemotherapy, reconstruction, and hysterectomy for Stage IIB ER-positive IDC, with all cancer-directed treatment completed by the end of 2019.

The Patient StoryRead more →

Amanda: Stage II Colorectal Cancer

Patient Info: Amanda, Female, Under 40 | Stage II

Completed surgery for Stage IIA colon cancer with clean resection, clear liver appearance, and 28 clear lymph nodes; follow-up colonoscopy surveillance moved from yearly to every 3 years.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Jackie's Patient Story

Patient Info: Jackie, Female | Stage IV

Biomarkers: Lynch syndrome

Metastatic Site: Not reported

Jackie’s Stage IIIB rectal cancer later recurred as Stage IV/metastatic disease, but early immunotherapy response was strong, with no visible tumor on MD Anderson sigmoid scope about 6 weeks after starting treatment.

The Patient StoryRead more →

Allison’s Stage 2C Colorectal Cancer Story

Patient Info: Allison, Female, Under 40 | Stage II

As of June 2026, Allison was sharing her Stage IIC colorectal cancer experience as a patient advocate after concurrent radiation/Xeloda, major surgery with J-pouch and temporary ileostomy, and chemotherapy.

The Patient StoryRead more →

Stage II BRCA1 Breast Cancer: Joy's Survivor Story

Patient Info: Joy R., Female | Stage II

Biomarkers: BRCA1 mutation

As of June 2026, Joy had no evidence of disease after chemotherapy, double mastectomy, and hysterectomy for Stage II breast cancer with a BRCA1 mutation, and had moved from 3-month to 6-month oncology monitoring.

The Patient StoryRead more →

Stage III Colorectal Cancer: Maria's Survivor Story

Patient Info: Maria, Female | Stage III

Maria’s PET scan came back clear after 7 months of chemotherapy, 7 weeks of radiation, and surgery for Stage IIIC rectal cancer, but she described herself as still under surveillance with blood tests every 6 months and not cancer-free until 5 years.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Ken's Patient Story

Patient Info: Ken, Male, 50s | Stage IV

Metastatic Site: Liver

As of May 2026, Ken was more than 3 years into Stage IV colorectal cancer. He was not cancer-free or NED, but described the disease as minimal and manageable with surveillance, maintenance chemotherapy/targeted therapy, and occasional ablation.

The Patient StoryRead more →

Colorectal cancer mimic: benign isolated colonic neurofibroma treated with hemicolectomy

Patient Info: Anonymized, Male

Biomarkers: CEA was normal before surgery. Final pathology showed benign neurofibroma, not colorectal cancer; lymph node was reactive only.

As of May 2026, the benign cecal neurofibroma had been completely resected with negative margins, symptoms resolved, and there was no recurrence at 3 years.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Carrie's Patient Story

Patient Info: Carrie, Female | Stage IV

Metastatic Site: ovaries; uterus; retroperitoneal/behind-kidney tumor

As of May 2026, Carrie had recurrent Stage IV signet ring cell colon cancer after a prior no-evidence-of-disease period and was receiving more aggressive chemotherapy plus radiation after surgery for a tumor behind the kidney.

The Patient StoryRead more →

EGFR-mutated Stage IV lung cancer with later brain progression

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: EGFR exon 19 deletion; acquired EGFR C797S mutation; acquired ROS1 rearrangement

Metastatic Site: brain|bone

She died about 20 months after diagnosis after brain progression and a severe postoperative stroke.

PubMed CentralRead more →

Growing teratoma syndrome after ovarian germ cell tumor treatment: Case 1

Patient Info: Anonymized, Female, Under 40

Biomarkers: AFP and beta-hCG elevated

Five months after completing therapy, her tumor markers were normal and there was no evidence of disease.

PubMed CentralRead more →

Growing teratoma syndrome after ovarian germ cell tumor treatment: Case 2

Patient Info: Anonymized, Female, Under 40 | Stage III

Biomarkers: AFP and beta-hCG elevated

After surgery and completion of chemotherapy in January 2025, she was without disease and her tumor markers were normal.

PubMed CentralRead more →